UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical pharmacology and therapeutics, ISSN 0009-9236, 09/2014, Volume 96, Issue 3, pp. 349 - 359
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Predictive Value of Tests | Pharmaceutical Preparations - blood | Caffeine - administration & dosage | Cytochrome P-450 Enzyme Inhibitors | Dried Blood Spot Testing | Humans | Omeprazole - blood | Bupropion - blood | Midazolam - administration & dosage | Substrate Specificity | Male | Chromatography, High Pressure Liquid | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Coffee | Terfenadine - administration & dosage | Caffeine - pharmacokinetics | Feasibility Studies | Enzyme Inhibitors - administration & dosage | Young Adult | Chromatography, Reverse-Phase | Tandem Mass Spectrometry | Capsules | Spectrometry, Mass, Electrospray Ionization | Flurbiprofen - administration & dosage | Adult | Dextromethorphan - pharmacokinetics | Terfenadine - blood | ATP-Binding Cassette, Sub-Family B, Member 1 - blood | Pharmaceutical Preparations - administration & dosage | Terfenadine - pharmacokinetics | Bupropion - pharmacokinetics | Flurbiprofen - pharmacokinetics | Cytochrome P-450 Enzyme System - blood | Administration, Oral | Isoenzymes | Caffeine - blood | Omeprazole - administration & dosage | Terfenadine - analogs & derivatives | Omeprazole - pharmacokinetics | Carbonated Beverages | Midazolam - pharmacokinetics | Bupropion - administration & dosage | Dextromethorphan - blood | Flurbiprofen - blood | Phenotype | Pilot Projects | Midazolam - blood | Dextromethorphan - administration & dosage | Usage | Glycoproteins | Liquid chromatography | Research | Pharmacokinetics | Cytochrome P-450 | Index Medicus | Abridged Index Medicus
Journal Article
European journal of clinical pharmacology, ISSN 0031-6970, 5/2009, Volume 65, Issue 5, pp. 435 - 442
Omeprazole | Bromazepam | Paracetamol | Biomedicine | Bioavailability | Nasogastric route | Oral route | Pharmacology/Toxicology | Pharmacokinetics | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Anti-Anxiety Agents - administration & dosage | Prospective Studies | Analgesics, Non-Narcotic - pharmacokinetics | Area Under Curve | Humans | Omeprazole - blood | Acetaminophen - administration & dosage | Half-Life | Biological Availability | Bromazepam - administration & dosage | Male | Metabolic Clearance Rate | Anti-Ulcer Agents - blood | Anti-Ulcer Agents - pharmacokinetics | Anti-Anxiety Agents - pharmacokinetics | Acetaminophen - blood | Bromazepam - blood | Intubation, Gastrointestinal | Female | Analgesics, Non-Narcotic - blood | Reproducibility of Results | Administration, Oral | Omeprazole - administration & dosage | Omeprazole - pharmacokinetics | Analgesics, Non-Narcotic - administration & dosage | Anti-Ulcer Agents - administration & dosage | Cross-Over Studies | Anti-Anxiety Agents - blood | Bromazepam - pharmacokinetics | Acetaminophen - pharmacokinetics | Cohort Studies | Therapeutic Equivalency | Acetaminophen | Analysis | Pharmacy | Index Medicus
Journal Article
3.
Full Text
Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients
Annals of surgery, ISSN 0003-4932, 08/2013, Volume 258, Issue 2, pp. 262 - 269
furosemide | oral cocktail | CYP3A | gastric bypass | drug metabolism | Life Sciences & Biomedicine | Surgery | Science & Technology | Gastric Bypass | Diuretics - pharmacokinetics | Excitatory Amino Acid Antagonists - pharmacokinetics | Humans | Middle Aged | Tolbutamide - urine | Male | Caffeine - pharmacokinetics | Midazolam - urine | Anti-Ulcer Agents - pharmacokinetics | Young Adult | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Diuretics - urine | Diuretics - administration & dosage | Hypoglycemic Agents - pharmacokinetics | Administration, Oral | Furosemide - pharmacokinetics | Omeprazole - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Hypoglycemic Agents - urine | Omeprazole - urine | Central Nervous System Stimulants - pharmacokinetics | Midazolam - blood | Dextromethorphan - urine | Adolescent | GABA Modulators - urine | Central Nervous System Stimulants - urine | Dextromethorphan - administration & dosage | Furosemide - administration & dosage | Tolbutamide - administration & dosage | Tolbutamide - pharmacokinetics | Caffeine - administration & dosage | Omeprazole - blood | GABA Modulators - pharmacokinetics | Midazolam - administration & dosage | Anti-Ulcer Agents - blood | Chromatography, High Pressure Liquid | Case-Control Studies | Excitatory Amino Acid Antagonists - urine | Hypoglycemic Agents - blood | Tandem Mass Spectrometry | Biotransformation | Adult | Female | Dextromethorphan - pharmacokinetics | Furosemide - urine | Caffeine - urine | Caffeine - blood | GABA Modulators - administration & dosage | GABA Modulators - blood | Omeprazole - pharmacokinetics | Anti-Ulcer Agents - urine | Midazolam - pharmacokinetics | Anti-Ulcer Agents - administration & dosage | Dextromethorphan - blood | Excitatory Amino Acid Antagonists - blood | Tolbutamide - blood | Aged | Central Nervous System Stimulants - blood | Pharmacokinetics | Central Nervous System Stimulants - administration & dosage | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 905 - 913
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bacterial diseases of the digestive system and abdomen | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Miscellaneous | Infectious diseases | Bacterial diseases | Human bacterial diseases | Biological and medical sciences | Medical sciences | Tablets | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Young Adult | Helicobacter pylori | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Clarithromycin - adverse effects | Organometallic Compounds - adverse effects | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | Breath Tests | Omeprazole - adverse effects | Tetracycline - adverse effects | Anti-Ulcer Agents - administration & dosage | Adolescent | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Drug Combinations | Organometallic Compounds - administration & dosage | Omeprazole | Gastrointestinal diseases | Research | Diagnosis | Drug therapy, Combination | Drug therapy | Comparative analysis | Health aspects | Studies | Histology | Clinical medicine | Drug resistance | Index Medicus | Abridged Index Medicus
Journal Article
Journal of nephrology, ISSN 1121-8428, 12/2014, Volume 27, Issue 6, pp. 659 - 666
Nephrology | Phase I | Medicine & Public Health | Urology/Andrology | Hyperphosphatemia | Chronic kidney disease | Pharmacokinetics | Sucroferric oxyhydroxide | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Digoxin - adverse effects | Diuretics - pharmacokinetics | Chelating Agents - administration & dosage | Humans | Middle Aged | Half-Life | Male | Metabolic Clearance Rate | Angiotensin II Type 1 Receptor Blockers - pharmacokinetics | Warfarin - administration & dosage | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Cardiotonic Agents - adverse effects | Diuretics - blood | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Diuretics - administration & dosage | Risk Assessment | Furosemide - pharmacokinetics | Cardiotonic Agents - pharmacokinetics | Omeprazole - administration & dosage | Sucrose - adverse effects | Anticoagulants - adverse effects | Anticoagulants - blood | Cardiotonic Agents - administration & dosage | Models, Biological | Ferric Compounds - adverse effects | Losartan - administration & dosage | Diuretics - adverse effects | Furosemide - administration & dosage | Angiotensin II Type 1 Receptor Blockers - adverse effects | Anticoagulants - administration & dosage | Area Under Curve | Losartan - blood | Omeprazole - blood | Warfarin - adverse effects | Ferric Compounds - administration & dosage | Healthy Volunteers | Furosemide - adverse effects | Adult | Female | Proton Pump Inhibitors - blood | Digoxin - blood | Losartan - pharmacokinetics | Chelating Agents - adverse effects | Furosemide - blood | Sucrose - administration & dosage | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Models, Statistical | Digoxin - pharmacokinetics | Warfarin - pharmacokinetics | Proton Pump Inhibitors - pharmacokinetics | Digoxin - administration & dosage | Cardiotonic Agents - blood | Warfarin - blood | Losartan - adverse effects | Anticoagulants - pharmacokinetics | Angiotensin II Type 1 Receptor Blockers - blood | Drug Combinations | Index Medicus | Original
Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 06/2019, Volume 49, Issue 11, pp. 1385 - 1394
Gastroenterology & Hepatology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Bismuth - administration & dosage | Drug Administration Schedule | Esomeprazole - administration & dosage | Humans | Metronidazole - administration & dosage | Middle Aged | Male | Treatment Outcome | Young Adult | Helicobacter pylori | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Adolescent | Clarithromycin - administration & dosage | Adult | Female | Aged | Amoxicillin - administration & dosage | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage | Levofloxacin - administration & dosage | Omeprazole | Therapy | Levofloxacin | Clarithromycin | Randomization | Amoxicillin | Bismuth | Infections | Metronidazole | Antimicrobial resistance | Index Medicus
Journal Article
7.
Full Text
Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy
Digestive diseases and sciences, ISSN 0163-2116, 2/2015, Volume 60, Issue 2, pp. 458 - 464
Biochemistry, general | Levofloxacin | Allergy | Quinolone | Oncology | Eradication | Allergic | Transplant Surgery | Medicine & Public Health | Helicobacter pylori | Hepatology | Gastroenterology | Penicillin | Bismuth | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Predictive Value of Tests | Bismuth - administration & dosage | Prospective Studies | Humans | Middle Aged | Salvage Therapy | Helicobacter pylori - drug effects | Male | Rifabutin - administration & dosage | Proton Pump Inhibitors - administration & dosage | Time Factors | Antacids - adverse effects | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Penicillins - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Levofloxacin - administration & dosage | Drug Hypersensitivity - etiology | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Breath Tests | Treatment Outcome | Spain | Medication Adherence | Helicobacter pylori - isolation & purification | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Helicobacter Infections - microbiology | Urea | Antibacterial agents | Allergic reaction | Index Medicus | Abridged Index Medicus
Journal Article
Clinical pharmacokinetics, ISSN 0312-5963, 10/2017, Volume 56, Issue 10, pp. 1231 - 1244
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Omeprazole - metabolism | Caffeine - administration & dosage | Humans | Warfarin - metabolism | Cytochrome P-450 Enzyme System - metabolism | Midazolam - administration & dosage | Male | Healthy Volunteers | Warfarin - administration & dosage | Young Adult | Time Factors | Adult | Metoprolol - metabolism | Fasting - metabolism | Pharmaceutical Preparations - administration & dosage | Cytochrome P-450 CYP2C9 - metabolism | Caffeine - metabolism | Administration, Oral | Omeprazole - administration & dosage | Metoprolol - administration & dosage | Cytochrome P-450 CYP1A2 - metabolism | Cross-Over Studies | Administration, Intravenous | Pharmaceutical Preparations - metabolism | Cytochrome P-450 CYP2D6 - metabolism | Midazolam - metabolism | Drug Combinations
Journal Article
Clinical pharmacology and therapeutics, ISSN 0009-9236, 01/2011, Volume 89, Issue 1, pp. 65 - 74
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Proton Pump Inhibitors - pharmacology | Ticlopidine - pharmacology | Humans | Middle Aged | Half-Life | Male | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology | Enzyme Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - blood | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Omeprazole - pharmacology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Enzyme Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Omeprazole - administration & dosage | Enzyme Inhibitors - pharmacology | Omeprazole - adverse effects |